Neurava announced today that it completed an oversubscribed seed financing round worth proceeds of $2.26 million. Indianapolis-based Neurava develops a novel wearable device for mitigating the risk of sudden unexpected death in epilepsy (SUDEP). The device monitors and alerts for seizures, cardiorespiratory dysfunctions, and the impending risk of SUDEP. Neurava says it’s unlike any other […]